Annual ROE
-201.87%
-159.19%-372.99%
December 31, 2023
Summary
- As of February 7, 2025, CNTX annual return on equity is -201.87%, with the most recent change of -159.19% (-372.99%) on December 31, 2023.
- During the last 3 years, CNTX annual ROE has fallen by -162.60% (-414.06%).
- CNTX annual ROE is now -857.77% below its all-time high of 26.64%, reached on December 31, 2019.
Performance
CNTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-58.75%
-5.63%-10.60%
September 1, 2024
Summary
- As of February 7, 2025, CNTX quarterly return on equity is -58.75%, with the most recent change of -5.63% (-10.60%) on September 1, 2024.
- Over the past year, CNTX quarterly ROE has dropped by -5.63% (-10.60%).
- CNTX quarterly ROE is now -120.68% below its all-time high of 284.07%, reached on December 31, 2021.
Performance
CNTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CNTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -373.0% | -10.6% |
| 3 y3 years | -414.1% | +1.5% |
| 5 y5 years | -857.8% | +1.5% |
CNTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -832.0% | at low | -120.7% | +56.8% |
| 5 y | 5-year | -857.8% | at low | -120.7% | +56.8% |
| alltime | all time | -857.8% | at low | -120.7% | +56.8% |
Context Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -58.75%(+10.6%) |
| Jun 2024 | - | -53.12%(-60.9%) |
| Mar 2024 | - | -136.03%(+17.8%) |
| Dec 2023 | -201.87%(+373.0%) | -115.50%(+47.3%) |
| Sep 2023 | - | -78.39%(+31.4%) |
| Jun 2023 | - | -59.67%(+20.7%) |
| Mar 2023 | - | -49.45%(+33.2%) |
| Dec 2022 | -42.68% | -37.12%(+12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -33.15%(-22.3%) |
| Jun 2022 | - | -42.67%(-60.5%) |
| Mar 2022 | - | -108.03%(-138.0%) |
| Dec 2021 | -21.66%(-44.8%) | 284.07%(+596.4%) |
| Sep 2021 | - | 40.79%(+1.7%) |
| Jun 2021 | - | 40.12%(-240.1%) |
| Mar 2021 | - | -28.64%(-27.1%) |
| Dec 2020 | -39.27%(-247.4%) | -39.27% |
| Dec 2019 | 26.64% | - |
FAQ
- What is Context Therapeutics annual return on equity?
- What is the all time high annual ROE for Context Therapeutics?
- What is Context Therapeutics annual ROE year-on-year change?
- What is Context Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Context Therapeutics?
- What is Context Therapeutics quarterly ROE year-on-year change?
What is Context Therapeutics annual return on equity?
The current annual ROE of CNTX is -201.87%
What is the all time high annual ROE for Context Therapeutics?
Context Therapeutics all-time high annual return on equity is 26.64%
What is Context Therapeutics annual ROE year-on-year change?
Over the past year, CNTX annual return on equity has changed by -159.19% (-372.99%)
What is Context Therapeutics quarterly return on equity?
The current quarterly ROE of CNTX is -58.75%
What is the all time high quarterly ROE for Context Therapeutics?
Context Therapeutics all-time high quarterly return on equity is 284.07%
What is Context Therapeutics quarterly ROE year-on-year change?
Over the past year, CNTX quarterly return on equity has changed by -5.63% (-10.60%)